NEW YORK (AP) _ Synergy Pharmaceuticals Inc. (SGYP) on Thursday reported a loss of $34.5 million in its third quarter.
On a per-share basis, the New York-based company said it had a loss of 14 cents.
The biopharmaceutical company posted revenue of $11.1 million in the period.
In the final minutes of trading on Thursday, the company's shares hit 45 cents. A year ago, they were trading at $2.93.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGYP at https://www.zacks.com/ap/SGYP